↓ Skip to main content

Antitumour activity of a potent MEK inhibitor RDEA119/BAY 869766 combined with rapamycin in human orthotopic primary pancreatic cancer xenografts

Overview of attention for article published in BMC Cancer, September 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

patent
2 patents

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
29 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Antitumour activity of a potent MEK inhibitor RDEA119/BAY 869766 combined with rapamycin in human orthotopic primary pancreatic cancer xenografts
Published in
BMC Cancer, September 2010
DOI 10.1186/1471-2407-10-515
Pubmed ID
Authors

Qing Chang, Mark S Chapman, Jeffrey N Miner, David W Hedley

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 3%
Uruguay 1 3%
Unknown 27 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 28%
Other 4 14%
Professor > Associate Professor 4 14%
Student > Doctoral Student 3 10%
Student > Ph. D. Student 3 10%
Other 4 14%
Unknown 3 10%
Readers by discipline Count As %
Agricultural and Biological Sciences 8 28%
Medicine and Dentistry 8 28%
Biochemistry, Genetics and Molecular Biology 4 14%
Pharmacology, Toxicology and Pharmaceutical Science 2 7%
Chemistry 2 7%
Other 2 7%
Unknown 3 10%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 March 2021.
All research outputs
#4,746,961
of 22,985,065 outputs
Outputs from BMC Cancer
#1,225
of 8,351 outputs
Outputs of similar age
#20,902
of 99,274 outputs
Outputs of similar age from BMC Cancer
#6
of 50 outputs
Altmetric has tracked 22,985,065 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,351 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 99,274 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.